News Hub | News Direct

Social Network Whitepaper Introduces Bitcoin Staking and Layer 2 Protocol, Aiming to Scale Bitcoin

Earth Wallet

Social Network is the first decentralized Layer 2 Bitcoin Staking Protocol, has unveiled a whitepaper outlining a solution to address the scalability, cost-efficiency, and environmental sustainability of the Bitcoin network. By harnessing recent upgrades in Bitcoin, Ethereum, and the Nostr Protocol, this system addresses the challenges of high transaction fees and slow confirmations on Bitcoin, aiming to bring the scalability of social networks to the blockchain without relying on centralized intermediaries. The integration of Bitcoin Taproot Script with Ethereum Validators allows for efficient bundling of transactions into succinct zero-knowledge proofs, reducing the strain on the Bitcoin blockchain. In addition, the inclusion of Nostr ensures a trustless and efficient relay for large-scale data storage and availability of Bitcoin transactions. Everhusk, the author of the protocol, presents a solution to revolutionize the Bitcoin ecosystem. The goal is to make Bitcoin more scalable, cost-effective, and resilient to congestion, ultimately unlocking the potential for decentralized social networks on both Bitcoin and Ethereum. Sukhveer Sanghera, a long-time Bitcoin and Ethereum contributor, expressed his excitement about the project's future, stating, "The whitepaper marks the start of an exciting journey. Congestion on the Bitcoin Network from Ordinals and other media is a real problem, and by integrating with the Nostr protocol, we are excited to finally bring a real scaling solution to Bitcoin that can ultimately allow us to have decentralized social networks. The goal is to help our planet earth, and decentralizing social networks by scaling Bitcoin is the first step in a better earth for all.” For those interested in exploring the full whitepaper and gaining a deeper understanding of Social Network's approach, please visit social.network. About Social Network: Social Network Bitcoin Layer 2 is the first decentralized Layer 2 Bitcoin Staking protocol, providing a more scalable, cost-efficient, and greener Bitcoin network. With Social Network users have the ability to stake their BTC without any limits, enjoy instant withdrawals, benefit from competitive fees, and experience full decentralization with self-custody. The Social Network Bitcoin Layer 2 aims to lower transaction fees and data storage demands, enabling decentralized social networks to scale while reducing energy consumption for the Bitcoin network and benefiting the planet earth. Website | Twitter | Discord Contact Details Dan Edelstein PR@marketacross.com

January 22, 2024 05:27 AM Eastern Standard Time

News Release

Top 4 Spinal Injury Stocks for 2024 (NRX.V, NVRO, SYK, BSX)

CGR Spine

Investors eyeing dynamic opportunities in healthcare should take note of the burgeoning growth anticipated in the spinal cord injury market. Projections for robust advancements, driven by enhanced diagnosis and increased global healthcare spending, signal a lucrative trajectory from 2023 to 2032, with a significantly positive CAGR, according to Delveinsights. With the spinal cord injury market showing promising growth, let's explore key stocks that could offer potential returns in the evolving healthcare landscape. NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) is positioned as a pioneering force in biopharmaceuticals, with a primary focus on advancing the field of biologically-guided exosome therapy for traumatic spinal cord injuries. Founded on innovative technology, NurExone's flagship product, ExoPTEN, stands out as a potential game-changer. Administered intranasally, ExoPTEN represents a minimally invasive ExoTherapy designed to induce neuron regeneration and rewiring in traumatically damaged spinal cords. The company holds exclusive worldwide licenses from the Technion and Tel Aviv University, signifying its leadership in translating groundbreaking concepts into actionable solutions. Key milestones in NurExone's journey include a notable Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and Drug Administration (FDA). This crucial interaction, held on August 29, 2023, provided clear guidance for the manufacturing, preclinical, and clinical development plans of ExoPTEN. The FDA's endorsement of NurExone's proposed ExoPTEN release testing strategy and toxicity study strategy sets the stage for submitting an Investigational New Drug (IND) application by Q4 2024, with Phase 1/2 human clinical studies anticipated to commence in 2025. In tandem with its commitment to acute spinal cord injury treatments, NurExone secured a $1 million New Israeli Shekels grant from the Israel Innovation Authority. This grant fosters collaboration with Inteligex Inc. to develop an innovative hybrid therapy targeting chronic spinal cord injuries. The collaboration, approved by the Israel-Canada bilateral Eureka program, broadens NurExone's potential market focus. The FDA's grant of Orphan-Drug Designation (ODD) for ExoPTEN therapy on October 30, 2023, marks a pivotal milestone. This designation recognizes the therapy's potential impact on acute spinal cord injuries, offering NurExone significant benefits such as market exclusivity, financial incentives, and regulatory support. The ODD status streamlines the company's go-to-market strategy, signaling a promising path for ExoPTEN. NurExone's commitment to continuous innovation is evident in its laboratory tests unveiled on November 29, 2023. These tests showcased two proprietary small inhibiting RNA sequences targeting the Peri-Neural Network (PNN) complex, representing a significant advancement in spinal cord injury treatment. The potential for two new products in the company's portfolio underscores NurExone's dedication to diversifying its molecular arsenal. The company's financial vitality received a boost with the closure of a non-brokered private placement on January 5, 2024. Raising CAD$1,985,758.04, this investment reflects strong investor confidence in NurExone's technology and direction. The proceeds are earmarked for advancing development activities, expanding the intellectual property portfolio, and supporting overall corporate objectives. More recently, on January 17, 2024, NurExone's collaborative agreement with Inteligex Inc. was officially underway. This collaboration aims to combine Inteligex's expertise in cell-based therapies with NurExone's innovative exosome platform, focusing on developing therapies for chronic spinal cord injuries. Additionally, NurExone has entered into an agreement with bullVestor Medien GmbH to enhance awareness of its products in German-speaking countries. NurExone Biologic Inc. is at the forefront of biologically-guided exosome therapy, supported by a number of milestones and technological advancements. The journey from FDA interactions to collaborative partnerships and financial investments paints a comprehensive picture of NurExone's trajectory, positioning the company as a leader in reshaping the landscape of regenerative therapies for spinal cord injuries. Nevro Corporation (NYSE: NVRO), headquartered in Redwood City, California, stands at the forefront of the medical device industry, specializing in transformative solutions for chronic pain treatment. Focused on their mission to alleviate debilitating pain, Nevro developed the groundbreaking 10 kHz Therapy—an evidence-based, non-pharmacologic innovation that has positively impacted over 100,000 patients worldwide. One notable achievement is the publication of 24-month data from the SENZA Nonsurgical Refractory Back Pain (NSRBP) trial in the Journal of Neurosurgery: Spine. This trial demonstrated the profound benefits of Nevro's high-frequency spinal cord stimulation (SCS) system in managing chronic back pain. Patients experienced significant pain relief, improved function, and enhanced quality of life, with a noteworthy reduction in opioid usage. Moreover, Nevro's strategic acquisition of Vyrsa Technologies expands its portfolio to address chronic sacroiliac joint pain—an essential move in a market valued at over $2 billion and expected to witness double-digit growth. This acquisition positions Nevro to offer tailored therapies, driving long-term shareholder value and contributing to growth projections in 2024. The company's financial performance, highlighted in the fourth-quarter 2023 results, exceeded expectations, showcasing consistent growth and a focus on key pillars: commercial execution, market penetration, and profit progress. Despite a restructuring initiative, Nevro remains committed to innovation, as evidenced by its partnership with Carelon Healthcare to broaden spinal cord stimulation coverage for painful diabetic neuropathy. As Nevro continues to pioneer advancements in chronic pain treatment, its comprehensive solutions and strategic initiatives position it as a key player in the evolving landscape of medical device innovation. Stryker Corporation (NYSE: SYK), a trailblazer in the medical technology domain, recently achieved a historic milestone, surpassing $20 billion in annual sales for the first time in December 2023. This achievement underscores Stryker's global impact on over 130 million patients annually and solidifies its position as a major leader in the medical device industry. Specializing in MedSurg, Neurotechnology, Orthopaedics, and Spine, Stryker stands out for its commitment to innovation and improving healthcare outcomes. In the realm of spine-related technology, the company's Spine division has demonstrated notable advancements, showcasing a dedication to state-of-the-art solutions for surgeons and patients alike. Robbie Robinson, President of the Spine division, emphasized the company's exciting year with multiple product launches, highlighting the continued growth of the Spine business. Among these launches, the Q Guidance System with Spine Guidance Software stands out, receiving the prestigious 2022 Best Technology in Spine award for its contributions to surgical spine planning and navigation. Stryker's commitment to excellence is further evident in products like the Monterey AL Interbody System, incorporating Tritanium In-Growth Technology, and the Bone Mill+, designed for enhanced efficiency in bone milling. The OmniCurve curved balloon system adds another dimension to Stryker's offerings, providing surgeons with advanced capabilities and control. As Stryker achieves record-breaking financial success, its continuous innovation in spine-related technology positions the company as a key player with substantial potential in the medical device sector. Stay tuned for more insights into Stryker's financial results during its upcoming Q4 and full-year earnings call on January 30, 2024. Boston Scientific (NYSE: BSX), a global medical technology leader, has been at the forefront of transforming lives through innovative medical solutions for over 40 years. With a commitment to advancing science and addressing unmet patient needs, the company provides high-performance solutions that enhance healthcare outcomes. In a significant move, Boston Scientific recently completed the acquisition of Relievant Medsystems Inc., marking a milestone in its chronic pain portfolio. Relievant is renowned for its Intracept Intraosseous Nerve Ablation System, the only FDA-cleared therapy for vertebrogenic pain, a form of chronic low back pain. This acquisition strengthens Boston Scientific's position in advanced interventional chronic pain treatments, offering physicians a comprehensive selection of evidence-based options. The Intracept system utilizes basivertebral nerve ablation therapy and has garnered national coverage from major insurers like Anthem Blue Cross Blue Shield and Humana. These coverage expansions, along with existing agreements with Cigna Healthcare and local Medicare plans, significantly increase access to intracept treatments for over 150 million lives. Jim Cassidy, President of Neuromodulation at Boston Scientific, expressed enthusiasm about the revolutionary therapy's potential to help more people suffering from chronic pain. The acquisition, involving an $850 million upfront cash payment and additional contingent payments based on sales performance, is poised to enhance Boston Scientific's capabilities in addressing multiple pain targets. This strategic move reflects Boston Scientific's commitment to offering physicians and patients a diverse range of evidence-based treatment options, further solidifying its position as a leader in the evolving landscape of chronic pain solutions. Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, or assumptions of future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. Capital Gains Report (CGR), owned by RazorPitch Inc., is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR has been retained by Awareness Consulting to produce and distribute this content related to NRX. As part of that content, readers, subscribers, and webs are expected to read the full disclaimers and financial disclosure statement that can be found on our website capitalgainsreport.com All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR is not a fiduciary by virtue of any persons use of or access to this content. Contact Details CapitalGainsReport Mark McKelvie +1 585-748-6862 markrmckelvie@gmail.com

January 22, 2024 05:00 AM Eastern Standard Time

News Release

4 Of The Best Gold Stocks For 2024

CGR Gold

In December 2023, gold prices soared to an all-time high of $2,135.39/oz, propelled by a weakening U.S. dollar and anticipation of Federal Reserve rate cuts. As we continue into 2024, the focus shifts to the Fed's interest rate decisions, which are expected to be pivotal factors influencing gold prices. Forecasts indicate a short-term dip in gold prices, followed by a resurgence and an anticipated peak at $2,300/oz in 2025, according to JP & Morgan, setting the stage for a potentially lucrative year for gold. For investors eyeing gold's promising trajectory, gold mining stocks offer a unique entry point. These stocks provide a pathway to tap into the gold market's potential. Now, let's delve into four notable mining stocks that could benefit from rallying gold prices Collective Mining Ltd. (OTCQX: CNLMF) (TSX: CNL) is making significant progress in the exploration sector, with an emphasis on gold, silver, copper, and tungsten projects in Caldas, Colombia. Collective Mining, founded by the team that successfully sold Continental Gold Inc. to Zijin Mining for approximately $2 billion, is notable for its projects in a proven mining camp with ten fully permitted and operational mines nearby. The Guayabales flagship project revolves around the Apollo target, a substantial gold-silver-copper-tungsten porphyry system that comes directly to surface. As of 2023, Collective Mining had completed 92 drill holes, covering approximately 40,000 meters, with pending assay results. Highlight holes include 519 meters at 2.76 g/t gold equivalent and 503 meters at 2.02 g/t gold equivalent, both of which began from surface. The company has ambitious plans for 2024, aiming to deploy up to six rigs throughout the year and drill more than 40,000 metres. In 2024, Collective Mining's primary objectives include expanding the Apollo System, known for its robust gold-silver-copper-tungsten porphyry system. The company will also focus on exploring early-stage targets along the 4.5-kilometer porphyry corridor at Guayabales. Notable targets include Olympus, Trap, Plutus, Target X, and Tower Target. Last week, Collective announced a new major discovery at the Trap target, located northeast of the Apollo porphyry system. A sizable and consistent zone of precious metal mineralization was found in two diamond drill holes. It is thought to be the upper part of a porphyry system with even better potential below. Drill hole TRC-2 intercepted 646.0 meters at 0.81 g/t gold equivalent, including 301.5 meters at 1.01 g/t gold equivalent, while TRC-3 revealed multiple intervals of continuous mineralization. This is a remarkable start to a grass-roots discovery. Collective Mining's Executive Chairman, Ari Sussman, expressed enthusiasm about the discoveries at Guayabales, highlighting the company's aggressive exploration approach. With its 2024 drill program set to be the most ambitious yet, Collective Mining positions itself as a compelling player in the dynamic world of mineral exploration. As the company resumes drilling at Trap, investors await further assay results, anticipating a deeper understanding of this significant discovery. The ongoing success at Guayabales solidifies Collective Mining's position as a noteworthy player in the exploration sector. Aris Mining Corporation (TSX: ARIS) (NYSE-A: ARMN) stands tall in the gold mining landscape, strategically positioned in the Americas. Operating in Colombia and Guyana, Aris Mining achieved noteworthy success in 2023, producing 226,151 ounces of gold within the projected range of 220,000 to 240,000 ounces. CEO Neil Woodyer highlighted the company's accomplishments, emphasizing the fulfillment of production guidance at Segovia Operations and the ongoing operations of Marmato Upper Mine during the construction of the new Marmato Lower Mine. Anticipating a total gold production between 220,000 and 240,000 ounces in 2024, Aris Mining is steadfast in its growth trajectory. Aris Mining's expansion initiatives include enhancing the Segovia processing facility by 50% to 3,000 metric tons per day by early 2025. Simultaneously, the construction of the Marmato Lower Mine is underway, with the first gold pour expected in late 2025. With aspirations to produce around 500,000 ounces of gold in Colombia in 2026, Aris Mining solidifies its long-term vision. Key highlights from 2023 include consistent quarter-over-quarter increases in gold production, Segovia Operations achieving an AISC/oz of $1,139 for the nine months ending September 30, 2023, and substantial increases in mineral resource and reserve estimates. Aris Mining's exploration plans for 2024 involve a strategic investment of $21 million to capitalize on prior successes at Segovia Operations, aiming for further resource expansion. With a conscientious focus on responsible and formalized artisanal and small-scale mining, Aris Mining not only excels in production but also distinguishes itself through ethical and sustainable practices. The company's exploratory endeavors, strategic initiatives, and growth-oriented commitment position it as a pivotal force in the dynamic landscape of gold mining in the Americas. Barrick Gold Corporation (NYSE: GOLD) stands as a prominent figure in the gold and copper industry, recently disclosing preliminary production figures for both the full year and the fourth quarter of 2023. Despite facing challenges, such as equipment issues in the Dominican Republic mine and reduced output in the Nevada Gold Fields project, Barrick's full-year gold production reached 4.05 million ounces. Notably, the company experienced a sequential increase in the fourth quarter, with gold production hitting 1.05 million ounces. Copper production for the year stood at 420 million pounds, maintaining consistent performance across all three production sites. This performance, however, did not meet earlier forecasts, resulting in a 2.17% decline in annual gold production. In response to these challenges, Barrick showed tenacity by reporting increases in Q4 gold production, which were driven by strong performances at key sites. Looking ahead, the company anticipates an 8% to 10% increase in all-in sustaining costs (AISC) per ounce of gold. In contrast, copper's AISC is projected to be 2% to 4% lower than the previous quarter. Leadership remains a key focus, with President and CEO Mark Bristow set to lead the upcoming presentation on February 14, 2024. Barrick's overarching purpose is to build the world's most valued gold and copper company, emphasizing high-margin, long-life assets managed by the best people. As investors navigate the dynamic landscape of mining stocks in 2024, Barrick Gold Corporation offers a compelling narrative, showcasing resilience in the face of challenges and providing a strategic outlook for the future. The upcoming quarterly report presentation promises a deeper understanding of Barrick's financial health and growth prospects. Newmont Corporation (NYSE: NEM), with a rich history spanning over a century, holds the distinction of being the largest gold-mining stock based on market capitalization and stands as the sole gold producer included in the S&P 500. The company's appeal has significantly increased following the completion of its acquisition of Newcrest in November. This strategic move is anticipated to bring immediate value, with Newmont projecting $500 million in pre-tax synergies over the two years following the deal's closure. Additionally, the company aims for a minimum of $2 billion in cash improvements through portfolio optimization during the same period. Examining Newmont's cash flow potential, the company reported operating cash flow of $1 billion for Q3 2023. With the combined impact of a higher gold price and the benefits derived from the acquisition, Newmont is poised for an operating cash flow exceeding $5 billion in 2024. Recently, the company disclosed its plan to release full-year and fourth-quarter 2023 operations and financial results, along with 2024 guidance, on Thursday, February 22, 2024. Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, or assumptions of future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. Capital Gains Report (CGR), owned by RazorPitch Inc., is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR has been retained by Collective Mining Ldt to produce and distribute this content. As part of that content, readers, subscribers, and webs are expected to read the full disclaimers and financial disclosure statement that can be found on our website capitalgainsreport.com All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR is not a fiduciary by virtue of any persons use of or access to this content. Contact Details CapitalGainsReport Mark McKelvie +1 585-301-7700 markrmckelvie@gmail.com Company Website http://CapitalGainsReport.com

January 22, 2024 05:00 AM Eastern Standard Time

ApeX Protocol Unveils Trade-to-Earn Round 2 with Enhanced Rewards Pool & Extra Layers of Incentives

ApeX

ApeX Protocol, a leading player in the cryptocurrency trading space and one of the top non-custodial derivatives decentralized exchanges (DEX), is thrilled to announce the highly anticipated launch of Trade-to-Earn (T2E) Round 2 as of January 22, 2024. Following the success of the inaugural event in November 2022, T2E Round 2 promises an even more rewarding experience for ApeX traders with enhanced incentives and a revamped rewards structure. T2E is a 52-week long program where traders can earn rewards based on their trading activity. The more trades executed, the greater the rewards accumulated. This year, ApeX is introducing exciting updates to make the journey even more rewarding for participants. Key Highlights of T2E Round 2: Introduction of $BANANA Token: T2E Round 2 is facilitated by a new $BANANA token on the Ethereum network. A total of 10,000,000 $APEX is locked over a 12-month period to mint $BANANA, at an initial redeem rate of 0.001. Reward tokens, distributed automatically on a bi-weekly basis, will be granted to users trading USDT perpetual contracts on ApeX Pro. Enhanced Rewards Pool with Potential Airdrop Opportunities: T2E Round 2 introduces an enhanced rewards pool, providing extra layers of incentives and benefits for ApeX traders with potential airdrop opportunities. In addition to $BANANA rewards, participants have the opportunity to claim rewards in partner project tokens. The distribution of airdrop rewards will be determined by traders' activities (T2E score) and project-specific factors in the coming months. Maximizing Rewards in 3 Steps: Swap: $BANANA can be easily swapped for USDT via the $BANANA-USDT pool at any time during the 52 weeks. Add Liquidity: By adding $BANANA and USDT to the $BANANA-USDT Pool, traders can acquire LP Tokens. Greater LP token holdings result in amplified $BANANA rewards at the conclusion of each epoch. Hold and Redeem: Holders of $BANANA can redeem $APEX governance tokens on a pro-rata basis after the event period. Acquired $APEX can be utilized in ApeX's revenue-sharing program through staking, further enhancing users' holdings with an additional passive income-generating tool on ApeX. Creating Value for the Community T2E events are aligned with the principles of crypto and decentralized finance, aiming to reciprocate to the community by enabling them to grow their wealth in a fair, transparent, and rewarding manner. Tekla I, the Head of Business Development at ApeX Protocol, expressed her enthusiasm about the launch: "We are excited to welcome traders back for the second iteration of Trade-to-Earn. T2E Round 2 is a testament to our commitment to providing our community with innovative and rewarding opportunities in the crypto space. At ApeX, we believe in the synergy between decentralization and community. T2E Round 2 is our way of rewarding our community for their contributions and dedication to our platform." About ApeX ApeX is a permissionless and non-custodial derivatives decentralized exchange, powered by StarkWare's Layer 2 scalability engine StarkEx, delivering USDC and USDT cross-margined perpetual contracts with over 30 trading pairs and up to 50x leverage. It is primed to provide permissionless access to the perpetual swaps market with its order book model, as it remains committed to the promises of speed, efficiency, and security with transparency on traders' preferred derivatives trading assets. Website | Twitter | Discord | Telegram | Blog Contact Details Mariam I mariam@davionlabs.com

January 22, 2024 04:54 AM Eastern Standard Time

Image

RZ Publish Nooro Foot Massager Reviews: Why It Is Used In The United States?

Spark Metro

Are you tired of living with constant burning and tingling in your feet due to neuropathy? Frustrated with painkillers that merely numb the discomfort without addressing the root cause? If so, you're not alone. Many have experienced the struggle of seeking relief from neuropathic pain, only to find temporary solutions. However, you are lucky to have come across this review because it is a comprehensive report about a breakthrough device popularly known as Nooro Foot Massager that goes beyond masking the symptoms, offering a chance to reverse nerve damage and regain a life free from persistent foot pain. In a world where traditional remedies may involve uncomfortable movements, Dr. Jeremy Campbell, in collaboration with the innovative med tech startup Nooro, introduces Nooro Foot Massager as a simple at-home solution for foot pain powered by Neuromuscular Electrical Stimulation (NMES) technology. This is where the story takes a turn towards hope and healing. Are you ready to break free from neuropathic pain and experience the relief you've been longing for? The Nooro Foot Massager might just be your key to a new lease on life. What Is Nooro Foot Massager? Nooro Foot Massager is a revolutionary at-home solution developed through the collaboration of Dr. Jeremy Campbell and the innovative med tech startup, Nooro. Designed to address neuropathic foot pain, Nooro Foot Massager device employs NeuroMuscular Electrical Stimulation (NMES) technology to offer relief in the comfort of your home. Specifically named the Nooro Foot Massager, this device stands out by delivering a unique combination of targeted electric impulses deep into the tissues of your feet and legs. The primary goal? To kickstart blood circulation, a crucial factor in providing the oxygen necessary for nerve recovery. By enhancing blood flow to your feet, the Nooro Foot Massager becomes a catalyst for nerve repair and healing. This breakthrough approach holds the promise of reducing the burning pain, tingling, and numbness associated with neuropathy. The ultimate result? A chance to reclaim the activities you love, free from the constant foot pain and swelling that may have confined you. This user-friendly device opens doors to a life where neuropathic pain no longer dictates your daily experiences, offering a pathway to comfort and mobility. In essence, the Nooro Foot Massager is more than just a device – it's a transformative tool designed to empower you on your journey to relief from neuropathic foot pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Features (Nooro Foot Massager Reviews USA) EMS Technology: The Nooro Foot Massager employs advanced NeuroMuscular Electrical Stimulation (EMS) technology. This technology facilitates the penetration of steady electric impulses deep into the tissues of the feet and legs, aiming to relieve muscle tension, increase blood circulation, and strengthen weakened muscles. Cordless Convenience: The Nooro EMS Foot Massager offers a cordless design, eliminating the hassle of dealing with tangled cords during use. Charging is simple using the provided electricity plug and cable, ensuring a convenient and clutter-free experience. Optional Preparatory Step: While optional, the recommendation to wash your feet and remove excess skin before using the massager adds a thoughtful touch. This preparatory step enhances the overall effectiveness of the massage treatment, promoting a more thorough and satisfying experience. Versatile Massage Modes: The device features a variety of different modes, providing users with options to cater to their specific needs. Whether you're looking to relax after a long day or target particular muscle groups causing discomfort, the Nooro Foot Massager's versatility ensures a customized and enjoyable experience. Adjustable Intensity Levels: Tailoring the massage experience to individual preferences, the massager offers a mind-bending number of speed settings. This wide range allows users to find the perfect intensity level, ensuring that the massage is both effective and comfortable for various muscle groups. User-Friendly Operation: The massager's simplicity is a standout feature. With easy-to-follow steps—place your feet on the foot pad, select the mode, and adjust intensity—you can initiate the massage effortlessly. The user-friendly design ensures that anyone can enjoy the benefits without a steep learning curve. Effective Neuropathy Relief: The Nooro Foot Massager is specifically designed to address neuropathic foot pain. By enhancing blood circulation, relieving muscle tension, and providing a targeted massage experience, the device aims to alleviate burning pain, tingling, and numbness. Users can experience liberation from the challenges of neuropathy, promoting overall foot health and well-being. Benefits Of Nooro Foot Massager Pain Alleviation: A primary benefit of the Nooro Foot Massager is its ability to ease neuropathic foot pain. By employing advanced EMS technology, the massager delivers targeted electric impulses to alleviate burning sensations and discomfort associated with neuropathy. Users may experience significant relief from persistent foot pain. Tingling Relief: This innovative EMS massager targets nerve-related tingling sensations by enhancing blood circulation. Through its unique combination of electric impulses, the Nooro Foot Massager aims to improve oxygen supply to peripheral nerves, reducing tingling and promoting a sense of comfort. Numbness Reduction: For individuals experiencing numbness due to neuropathy, the Nooro Foot Massager offers hope. By increasing blood flow to the feet and facilitating nerve repair, the device strives to reduce numbness, allowing users to regain sensation in their extremities. Improved Blood Circulation: A core benefit lies in the massager's ability to enhance blood circulation. The EMS technology stimulates blood flow to the feet and legs, ensuring a continuous supply of oxygen to nerve cells. Improved circulation contributes not only to pain relief but also to overall foot health. Muscle Strengthening: Beyond addressing neuropathic pain, the Nooro Foot Massager helps strengthen weakened muscles. The electric impulses penetrate deep into the tissues, promoting muscle stimulation. This additional benefit contributes to overall foot strength and may aid in preventing future discomfort. Convenience and Comfort: The cordless design, along with the straightforward operational steps, adds a layer of convenience to the user experience. The Nooro Foot Massager provides a hassle-free solution for those seeking comfort and relief. Users can enjoy the benefits of a personalized massage without the inconvenience of cords or complicated setup. How Does Nooro Foot Massager Work? (Nooro Foot Massager Reviews) The Nooro EMS Foot Massager operates on advanced EMS (Electrical Muscle Stimulation) technology, offering a multi-faceted approach to relieving discomfort. True to its name, using this device is as simple as placing your feet on it and letting it work its magic. Specifically, Nooro EMS Foot Massager works by increasing blood flow to your feet, the massager facilitates the delivery of much-needed oxygen to nerve cells. This groundbreaking approach opens the door to nerve repair and healing, reducing burning pain, tingling, and numbness. But here's the beauty of it – as long as your nerves are alive, there's hope for reversal. The National Institute of Health emphasizes the regenerative capacity of peripheral nerves when the underlying nerve cell remains intact. The Nooro Foot Massager becomes a tool for revitalization, offering relief and a chance to reclaim a life without constant foot pain. This innovative massager employs steady electric impulses that penetrate deep into your feet and legs, effectively targeting muscle tension. The result? Relaxation of tense muscles, which is essential for alleviating discomfort associated with neuropathic foot pain. What sets the Nooro Foot Massager apart is its versatility. With a variety of modes and an impressive array of speed settings, the device allows you to tailor your experience to address specific muscle groups. This flexibility ensures that you can find a satisfying combination, catering to the unique needs of whatever muscle group is causing you distress. In essence, the Nooro Foot Massager is designed to be user-friendly and customizable. Its cutting-edge EMS technology aims to enhance blood circulation, relieve muscle tension, and strengthen weakened muscles, all while providing a hassle-free experience. So, whether you're looking to unwind after a long day or target specific muscle groups causing discomfort, this device offers a personalized solution to meet your needs. Who Needs Nooro Foot Massager? Foot Pain and Discomfort: If your feet hurt or feel uncomfortable, the Nooro Foot Massager can give you relief and make you feel better. Plantar Fasciitis: If you have plantar fasciitis (pain in the bottom of your feet), using the massager can help ease the pain and make your feet more comfortable. Athletes and Runners: Athletes and runners can use the massager to relax their muscles and recover faster after exercising. Diabetes: If you have diabetes and your feet need extra care, the Nooro Foot Massager can be part of your routine to keep your feet comfortable. Swelling: If your feet are swollen, especially during pregnancy or due to certain health issues, the Nooro Foot Massager can help reduce the swelling. General Well-being: If you just want to feel better overall and more relaxed, using the Nooro Foot Massager can contribute to your well-being. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE AT A MASSIVE DISCOUNT Does Nooro EMS Foot Massager Really Work? Absolutely, the Nooro EMS Foot Massager has garnered positive reviews from satisfied customers, attesting to its effectiveness. Users express genuine satisfaction with the relief it provides, particularly in addressing knee-related concerns. Many have reported that it contributes to a positive sensation in their knees, offering comfort and support, especially before bedtime. Customers dealing with foot pains have found solace in the Nooro Foot Massager. The device seems to provide tangible relief, soothing discomfort associated with foot pains. The positive feedback highlights the impact of the massager in helping alleviate foot-related issues, making it a promising solution for those seeking relief from foot pain. One user shared their experience, noting the immediate positive effects after just one use. This firsthand account emphasizes the rapid and noticeable benefits users can expect, further reinforcing the idea that the Nooro EMS Foot Massager indeed works to bring comfort and relief. In essence, the testimonials from customers reflect a consensus that the Nooro EMS Foot Massager is not just a device but a reliable solution that genuinely addresses pain and discomfort, particularly in the knees. The positive feedback from users reinforces the notion that the Nooro Foot Massager is effective in delivering the relief it promises. How To Use Nooro Foot Massager? Using the Nooro EMS Foot Massager is delightfully straightforward, making it a hassle-free addition to your routine. First and foremost, you'll appreciate the absence of annoying cords – charging is a breeze with the included electricity plug and cable that come with your order. Once charged, the process is as simple as 1-2-3. For an optimal experience, the second step is optional but recommended – give your feet a quick wash and remove any excess skin. This preparatory step significantly enhances the effectiveness of the massage treatment. Now, you're ready to indulge in the soothing benefits of the Nooro Foot Massager. Just place your feet on the foot pad, select your preferred mode, and adjust the intensity level of the massage to your liking. It's a customizable experience tailored to meet your unique needs. From there, all that's left to do is sit back comfortably and let the massager work its magic. As it eases pain, relieves tingling, and liberates you from the challenges of neuropathy, you'll find a newfound sense of comfort and relief. The Nooro Foot Massager brings simplicity and effectiveness together, making it a user-friendly solution for those seeking relief from neuropathic foot pain. Price Of Nooro Foot Massager And Where To Buy Nooro Foot Massager can be gotten directly from the manufacturer’s official website at the following prices: Single Unit: Buy one Nooro Foot Massager for $99.95. Two Units: Buy two Nooro Foot Massagers for $94.95 each. Total cost: $189.90. Three Units: Buy three Nooro Foot Massagers for $89.95 each. Total cost: $269.85. Four Units: Buy four Nooro Foot Massagers for $87.95 each. Total cost: $351.80. Six Units: Buy six Nooro Foot Massagers for $84.95 each. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Nooro Foot Massager Reviews Consumer Reports And Customer Complaints The Nooro EMS Foot Massager has received overwhelmingly positive consumer reports, with an impressive 4.8-star rating and a noteworthy achievement of zero customer complaints. Thousands of individuals have experienced successful outcomes in reversing neuropathy with this device, highlighting its efficacy and customer satisfaction. Harry Keegan - “Superb relaxation, it's not bulky, so you can take it anywhere, cheaper than other massagers, does what it says. You'll love the "cupping mode". Many intensity options (up to 19). It's a great product with fast shipping! My wife loves it…” Debra Peyton - “Should have bought Nooro Foot Massager earlier, exactly what I needed for my neuropathy-pained-feet. Honestly, I can walk and move with just minimal pain. I've only used it for like 2 days and I have felt better than I have in the past 2 years!!!” Clara Milton - “I absolutely love my Nooro EMS Foot Massager massager, had to get one for my daughter today since she wont stop using mine!” Final Verdict On Nooro EMS Foot Massager Reviews The overwhelming positive reviews and testimonials for the Nooro Foot Massager paint a compelling picture of its effectiveness and customer satisfaction. With a remarkable 4.8-star rating and zero customer complaints, it stands out as a reliable solution for those seeking relief from neuropathic foot pain. Customers like Harry Keegan commend the massager for its superb relaxation, portability, affordability, and diverse intensity options. The mention of the "cupping mode" adds to the device's appeal. Debra Peyton's experience reinforces the quick and tangible relief the Nooro Foot Massager provides, enabling her to walk with minimal pain after just two days of use. Clara Milton's enthusiasm and the decision to purchase an additional massager for her daughter further underscore the positive impact and effectiveness of the device. In the final verdict, the Nooro Foot Massager emerges as a standout product, praised for its user-friendly design, versatility, and ability to address neuropathy-induced foot pain. The absence of customer complaints reinforces its credibility, making it a promising choice for those in search of a reliable and effective solution to neuropathic pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely substitutes for sound medical or financial advice from a licensed healthcare provider or certified financial advisor. Make sure to consult with a professional physician or financial consultant before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary. These products are not intended to diagnose, treat, cure or prevent any disease and do not provide any kind of get-rich money scheme. Reviewer is not responsible for pricing inaccuracies. Check product sales page for final prices. Contact Details Review Zenith Alex +1 302-597-6768 Apexreviews154@gmail.com Company Website https://reviewzenith.com/

January 22, 2024 04:37 AM Eastern Standard Time

Image

RZ Publish Nooro Foot Massager Reviews: Why Is It Used In The United States?

Spark Metro

Are you tired of living with constant burning and tingling in your feet due to neuropathy? Frustrated with painkillers that merely numb the discomfort without addressing the root cause? If so, you're not alone. Many have experienced the struggle of seeking relief from neuropathic pain, only to find temporary solutions. However, you are lucky to have come across this review because it is a comprehensive report about a breakthrough device popularly known as Nooro Foot Massager that goes beyond masking the symptoms, offering a chance to reverse nerve damage and regain a life free from persistent foot pain. In a world where traditional remedies may involve uncomfortable movements, Dr. Jeremy Campbell, in collaboration with the innovative med tech startup Nooro, introduces Nooro Foot Massager as a simple at-home solution for foot pain powered by Neuromuscular Electrical Stimulation (NMES) technology. This is where the story takes a turn towards hope and healing. Are you ready to break free from neuropathic pain and experience the relief you've been longing for? The Nooro Foot Massager might just be your key to a new lease on life. What Is Nooro Foot Massager? Nooro Foot Massager is a revolutionary at-home solution developed through the collaboration of Dr. Jeremy Campbell and the innovative med tech startup, Nooro. Designed to address neuropathic foot pain, Nooro Foot Massager device employs NeuroMuscular Electrical Stimulation (NMES) technology to offer relief in the comfort of your home. Specifically named the Nooro Foot Massager, this device stands out by delivering a unique combination of targeted electric impulses deep into the tissues of your feet and legs. The primary goal? To kickstart blood circulation, a crucial factor in providing the oxygen necessary for nerve recovery. By enhancing blood flow to your feet, the Nooro Foot Massager becomes a catalyst for nerve repair and healing. This breakthrough approach holds the promise of reducing the burning pain, tingling, and numbness associated with neuropathy. The ultimate result? A chance to reclaim the activities you love, free from the constant foot pain and swelling that may have confined you. This user-friendly device opens doors to a life where neuropathic pain no longer dictates your daily experiences, offering a pathway to comfort and mobility. In essence, the Nooro Foot Massager is more than just a device – it's a transformative tool designed to empower you on your journey to relief from neuropathic foot pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Features (Nooro Foot Massager Reviews USA) EMS Technology: The Nooro Foot Massager employs advanced NeuroMuscular Electrical Stimulation (EMS) technology. This technology facilitates the penetration of steady electric impulses deep into the tissues of the feet and legs, aiming to relieve muscle tension, increase blood circulation, and strengthen weakened muscles. Cordless Convenience: The Nooro EMS Foot Massager offers a cordless design, eliminating the hassle of dealing with tangled cords during use. Charging is simple using the provided electricity plug and cable, ensuring a convenient and clutter-free experience. Optional Preparatory Step: While optional, the recommendation to wash your feet and remove excess skin before using the massager adds a thoughtful touch. This preparatory step enhances the overall effectiveness of the massage treatment, promoting a more thorough and satisfying experience. Versatile Massage Modes: The device features a variety of different modes, providing users with options to cater to their specific needs. Whether you're looking to relax after a long day or target particular muscle groups causing discomfort, the Nooro Foot Massager's versatility ensures a customized and enjoyable experience. Adjustable Intensity Levels: Tailoring the massage experience to individual preferences, the massager offers a mind-bending number of speed settings. This wide range allows users to find the perfect intensity level, ensuring that the massage is both effective and comfortable for various muscle groups. User-Friendly Operation: The massager's simplicity is a standout feature. With easy-to-follow steps—place your feet on the foot pad, select the mode, and adjust intensity—you can initiate the massage effortlessly. The user-friendly design ensures that anyone can enjoy the benefits without a steep learning curve. Effective Neuropathy Relief: The Nooro Foot Massager is specifically designed to address neuropathic foot pain. By enhancing blood circulation, relieving muscle tension, and providing a targeted massage experience, the device aims to alleviate burning pain, tingling, and numbness. Users can experience liberation from the challenges of neuropathy, promoting overall foot health and well-being. Benefits Of Nooro Foot Massager Pain Alleviation: A primary benefit of the Nooro Foot Massager is its ability to ease neuropathic foot pain. By employing advanced EMS technology, the massager delivers targeted electric impulses to alleviate burning sensations and discomfort associated with neuropathy. Users may experience significant relief from persistent foot pain. Tingling Relief: This innovative EMS massager targets nerve-related tingling sensations by enhancing blood circulation. Through its unique combination of electric impulses, the Nooro Foot Massager aims to improve oxygen supply to peripheral nerves, reducing tingling and promoting a sense of comfort. Numbness Reduction: For individuals experiencing numbness due to neuropathy, the Nooro Foot Massager offers hope. By increasing blood flow to the feet and facilitating nerve repair, the device strives to reduce numbness, allowing users to regain sensation in their extremities. Improved Blood Circulation: A core benefit lies in the massager's ability to enhance blood circulation. The EMS technology stimulates blood flow to the feet and legs, ensuring a continuous supply of oxygen to nerve cells. Improved circulation contributes not only to pain relief but also to overall foot health. Muscle Strengthening: Beyond addressing neuropathic pain, the Nooro Foot Massager helps strengthen weakened muscles. The electric impulses penetrate deep into the tissues, promoting muscle stimulation. This additional benefit contributes to overall foot strength and may aid in preventing future discomfort. Convenience and Comfort: The cordless design, along with the straightforward operational steps, adds a layer of convenience to the user experience. The Nooro Foot Massager provides a hassle-free solution for those seeking comfort and relief. Users can enjoy the benefits of a personalized massage without the inconvenience of cords or complicated setup. How Does Nooro Foot Massager Work? (Nooro Foot Massager Reviews) The Nooro EMS Foot Massager operates on advanced EMS (Electrical Muscle Stimulation) technology, offering a multi-faceted approach to relieving discomfort. True to its name, using this device is as simple as placing your feet on it and letting it work its magic. Specifically, Nooro EMS Foot Massager works by increasing blood flow to your feet, the massager facilitates the delivery of much-needed oxygen to nerve cells. This groundbreaking approach opens the door to nerve repair and healing, reducing burning pain, tingling, and numbness. But here's the beauty of it – as long as your nerves are alive, there's hope for reversal. The National Institute of Health emphasizes the regenerative capacity of peripheral nerves when the underlying nerve cell remains intact. The Nooro Foot Massager becomes a tool for revitalization, offering relief and a chance to reclaim a life without constant foot pain. This innovative massager employs steady electric impulses that penetrate deep into your feet and legs, effectively targeting muscle tension. The result? Relaxation of tense muscles, which is essential for alleviating discomfort associated with neuropathic foot pain. What sets the Nooro Foot Massager apart is its versatility. With a variety of modes and an impressive array of speed settings, the device allows you to tailor your experience to address specific muscle groups. This flexibility ensures that you can find a satisfying combination, catering to the unique needs of whatever muscle group is causing you distress. In essence, the Nooro Foot Massager is designed to be user-friendly and customizable. Its cutting-edge EMS technology aims to enhance blood circulation, relieve muscle tension, and strengthen weakened muscles, all while providing a hassle-free experience. So, whether you're looking to unwind after a long day or target specific muscle groups causing discomfort, this device offers a personalized solution to meet your needs. Who Needs Nooro Foot Massager? Foot Pain and Discomfort: If your feet hurt or feel uncomfortable, the Nooro Foot Massager can give you relief and make you feel better. Plantar Fasciitis: If you have plantar fasciitis (pain in the bottom of your feet), using the massager can help ease the pain and make your feet more comfortable. Athletes and Runners: Athletes and runners can use the massager to relax their muscles and recover faster after exercising. Diabetes: If you have diabetes and your feet need extra care, the Nooro Foot Massager can be part of your routine to keep your feet comfortable. Swelling: If your feet are swollen, especially during pregnancy or due to certain health issues, the Nooro Foot Massager can help reduce the swelling. General Well-being: If you just want to feel better overall and more relaxed, using the Nooro Foot Massager can contribute to your well-being. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE AT A MASSIVE DISCOUNT Does Nooro EMS Foot Massager Really Work? Absolutely, the Nooro EMS Foot Massager has garnered positive reviews from satisfied customers, attesting to its effectiveness. Users express genuine satisfaction with the relief it provides, particularly in addressing knee-related concerns. Many have reported that it contributes to a positive sensation in their knees, offering comfort and support, especially before bedtime. Customers dealing with foot pains have found solace in the Nooro Foot Massager. The device seems to provide tangible relief, soothing discomfort associated with foot pains. The positive feedback highlights the impact of the massager in helping alleviate foot-related issues, making it a promising solution for those seeking relief from foot pain. One user shared their experience, noting the immediate positive effects after just one use. This firsthand account emphasizes the rapid and noticeable benefits users can expect, further reinforcing the idea that the Nooro EMS Foot Massager indeed works to bring comfort and relief. In essence, the testimonials from customers reflect a consensus that the Nooro EMS Foot Massager is not just a device but a reliable solution that genuinely addresses pain and discomfort, particularly in the knees. The positive feedback from users reinforces the notion that the Nooro Foot Massager is effective in delivering the relief it promises. How To Use Nooro Foot Massager? Using the Nooro EMS Foot Massager is delightfully straightforward, making it a hassle-free addition to your routine. First and foremost, you'll appreciate the absence of annoying cords – charging is a breeze with the included electricity plug and cable that come with your order. Once charged, the process is as simple as 1-2-3. For an optimal experience, the second step is optional but recommended – give your feet a quick wash and remove any excess skin. This preparatory step significantly enhances the effectiveness of the massage treatment. Now, you're ready to indulge in the soothing benefits of the Nooro Foot Massager. Just place your feet on the foot pad, select your preferred mode, and adjust the intensity level of the massage to your liking. It's a customizable experience tailored to meet your unique needs. From there, all that's left to do is sit back comfortably and let the massager work its magic. As it eases pain, relieves tingling, and liberates you from the challenges of neuropathy, you'll find a newfound sense of comfort and relief. The Nooro Foot Massager brings simplicity and effectiveness together, making it a user-friendly solution for those seeking relief from neuropathic foot pain. Price Of Nooro Foot Massager And Where To Buy Nooro Foot Massager can be gotten directly from the manufacturer’s official website at the following prices: Single Unit: Buy one Nooro Foot Massager for $99.95. Two Units: Buy two Nooro Foot Massagers for $94.95 each. Total cost: $189.90. Three Units: Buy three Nooro Foot Massagers for $89.95 each. Total cost: $269.85. Four Units: Buy four Nooro Foot Massagers for $87.95 each. Total cost: $351.80. Six Units: Buy six Nooro Foot Massagers for $84.95 each. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Nooro Foot Massager Reviews Consumer Reports And Customer Complaints The Nooro EMS Foot Massager has received overwhelmingly positive consumer reports, with an impressive 4.8-star rating and a noteworthy achievement of zero customer complaints. Thousands of individuals have experienced successful outcomes in reversing neuropathy with this device, highlighting its efficacy and customer satisfaction. Harry Keegan - “Superb relaxation, it's not bulky, so you can take it anywhere, cheaper than other massagers, does what it says. You'll love the "cupping mode". Many intensity options (up to 19). It's a great product with fast shipping! My wife loves it…” Debra Peyton - “Should have bought Nooro Foot Massager earlier, exactly what I needed for my neuropathy-pained-feet. Honestly, I can walk and move with just minimal pain. I've only used it for like 2 days and I have felt better than I have in the past 2 years!!!” Clara Milton - “I absolutely love my Nooro EMS Foot Massager massager, had to get one for my daughter today since she wont stop using mine!” Final Verdict On Nooro EMS Foot Massager Reviews The overwhelming positive reviews and testimonials for the Nooro Foot Massager paint a compelling picture of its effectiveness and customer satisfaction. With a remarkable 4.8-star rating and zero customer complaints, it stands out as a reliable solution for those seeking relief from neuropathic foot pain. Customers like Harry Keegan commend the massager for its superb relaxation, portability, affordability, and diverse intensity options. The mention of the "cupping mode" adds to the device's appeal. Debra Peyton's experience reinforces the quick and tangible relief the Nooro Foot Massager provides, enabling her to walk with minimal pain after just two days of use. Clara Milton's enthusiasm and the decision to purchase an additional massager for her daughter further underscore the positive impact and effectiveness of the device. In the final verdict, the Nooro Foot Massager emerges as a standout product, praised for its user-friendly design, versatility, and ability to address neuropathy-induced foot pain. The absence of customer complaints reinforces its credibility, making it a promising choice for those in search of a reliable and effective solution to neuropathic pain. CLICK HERE NOW TO GET THE NOORO FOOT MASSAGER DIRECTLY FROM THE OFFICIAL WEBSITE Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely substitutes for sound medical or financial advice from a licensed healthcare provider or certified financial advisor. Make sure to consult with a professional physician or financial consultant before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary. These products are not intended to diagnose, treat, cure or prevent any disease and do not provide any kind of get-rich money scheme. Reviewer is not responsible for pricing inaccuracies. Check product sales page for final prices. Contact Details Review Zenith Alex +1 302-597-6768 Apexreviews154@gmail.com Company Website https://reviewzenith.com

January 22, 2024 04:12 AM Eastern Standard Time

Image

NSAV Announces FINCEN Registration

Net Savings Link Inc

Net Savings Link, Inc. (OTC: NSAV), a cryptocurrency, blockchain and digital asset technology company, announced today that it has been assigned a BSA ID registration number from FINCEN, to be regulated as a Money Services Business (MSB). The following was received by NSAV from FINCEN “Received acknowledgement for BSA Tracking Number MRX24-00001210. This RMSBX has been assigned BSA ID: 31000262776231 Filing Name: NSAV” NSAV released the following statement, “The FINCEN registration is the first step in achieving the regulatory goals we have outlined for the company. We look forward to systematically completing each step along this path as we navigate these uncharted markets.” NSAV's vision is the establishment of a fully integrated technology company, which provides turnkey technological solutions to the cryptocurrency, blockchain and digital asset industries. Over time, the Company plans to provide a wide range of services such as software solutions, e-commerce, financial services, advisory services and information technology. For further information please contact NSAV at info@nsavholdinginc.com The NSAVx Discord Server can be accessed at https://discord.com/invite/7Q2Vv5NmKd The NSAV Twitter account can be accessed at https://twitter.com/nsav_tech The NSAV corporate website can be accessed at http://nsavholdinginc.com The NSAV Centralized Cryptocurrency Exchange (CEX) website can be accessed at https://ex.nsavexchange.com/main The NSAV CEX Twitter account can be accessed at https://twitter.com/nsavcex The NSAVDEX Exchange website can be accessed at https://nsavdex.io/ The NSAV Premium OTC Crypto Trading Desk website can be accessed at https://nsavholdinginc.com/otc-desk/ The NSAV Hong Kong OTC Crypto Trading Desk website can be accessed at https://hkotc.co/ The NSAVDEX Exchange Telegram account can be accessed at https://t.me/NSAVDEXorg This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that, all forward-looking statements involve risks and uncertainties, including without limitation, the ability of Net Savings Link, Inc. to accomplish its stated plan of business. Net Savings Link, Inc. believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this press release will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as a representation by Net Savings Link, Inc. or any other person. Contact Net Savings Link, Inc. info@nsavholdinginc.com Contact Details Net Savings Link Inc James Tilton +1 718-569-8815 info@nsavholdinginc.com Company Website https://www.nsavholdinginc.com

January 22, 2024 03:00 AM Eastern Standard Time

Image

JUST IN: PawFury and CoinMarketCap Join Forces For a Strategic Marketing Partnership

Digital Tech Wire

New York, Jan. 21, 2024 - ( Digital Tech Wire ) -- As the digital finance sector witnesses another significant collaboration, PawFury, a burgeoning name in the DeFi and gaming arena, has announced an exclusive offer, celebrating its strategic partnership with CoinMarketCap. This move signifies PawFury's commitment to expanding its community and offering tangible benefits to its users. Special Offer for Early Investors To commemorate its alliance with CoinMarketCap, PawFury is rolling out a special promotional campaign. New investors and users are presented with a unique opportunity: a 10% EXTRA Bonus on their new investments. This bonus can be availed by using the Promo Code CMC10. This initiative is part of PawFury's efforts to welcome new members into its growing ecosystem and to provide added value to early supporters. A Golden Opportunity in Presale Stage PawFury's $PAW token is in its early bird presale stage, available at an attractively low price, offering a prime opportunity for early adopters and investors. This presale stage is particularly enticing, as buyers stand to gain a substantial 455% price discount from the current stage to the anticipated listing price of $0.0200. Such a significant markdown highlights the potential benefits for early-stage participants. Blending DeFi and Gaming PawFury is at the forefront of integrating decentralized finance with the engaging gaming world. This approach caters to hardcore DeFi enthusiasts and appeals to casual gamers, thus tapping into a diverse market. The platform's innovative blend of gaming dynamics with DeFi elements positions it as a unique player in the crypto space. Conclusion The partnership between PawFury and CoinMarketCap, with the enticing presale offer, underscores the platform's potential in the DeFi and gaming sectors. This collaboration and the ensuing promotional campaign signify PawFury's growing influence and its commitment to providing value to its community. Interested parties are encouraged to take advantage of this limited-time offer, stepping into a world where gaming meets finance. For more information and to participate in the presale, visit PawFury’s Presale Page. Written by Adam Sullivan Expert in Cryptocurrency and Blockchain Analysis. info@digitaltechwire.com Disclaimer: This article is for informational purposes only and does not constitute investment advice. The crypto market is volatile, and readers are advised to conduct their own research before making any investment decisions. Contact Details Adam Sullivan, Expert in Cryptocurrency and Blockchain Analysis adam@digitaltechwire.com

January 21, 2024 08:24 AM Eastern Standard Time

Image

Dunstan Joins Horse Racing Syndicate Racing Club’s Stable

Acroud Media

Racing Club have added Dunstan to their ever-expanding portfolio of racehorses available for shared ownership. Dunstan is a promising 3YO colt who has finished runner-up in four of his six career starts to date, including a solid effort on his stable debut at Lingfield Park in December. There are high hopes for the youngster, and he’s an exciting recruit to the Racing Club team. Dunstan will be trained at Newlands in Upper Lambourn, Berkshire, by Barry Brennan. There are 1,500 racing shares available in Dunstan priced at £62. As a shareholder you will receive: Regular Jockey and Trainer Updates on Dunstan Opportunity to visit Dunstan at Newlands Stables Share of any Prize Money Dunstan Wins Ballot system for Owners Badges when Dunstan races Access to Racing Club Events at the Races and other events Exclusive Members Area to access all Benefits Racing Club is an innovative provider of racing syndicates aiming to bring like-minded individuals together to build a community with the focus on great entertainment. Shares start from as little as £45 per year! As well as providing regular updates on the syndicate horses, opportunities to visit the stables and gallops and a share in any prize money, Racing Club also run monthly ballots to win hospitality tickets to The O2, Wembley, Southampton FC and Newbury Racecourse. Racing Club also offer a VIP service for those looking to purchase a bigger share or outright ownership of a horse. Full details of all horses currently for sale can be found at www.racingclub.com Richard Jaques, Co-Founder of Racing Club added ‘We are delighted to add Dunstan to our portfolio of Racehorses. He is an exciting colt and we look forward to seeing him develop and race in the months ahead.’ Further details can be found at www.racingclub.com or any enquiries can be made via info@racingclub.com For regular updates and latest news follow Racing Club on Twitter@Racingclubvip Contact Details Acroud Media info-media@acroudmedia.com

January 20, 2024 04:00 AM Eastern Standard Time

Image

All Industries

Social Network Whitepaper Introduces Bitcoin Staking and Layer 2 Protocol, Aiming to Scale Bitcoin

Top 4 Spinal Injury Stocks for 2024 (NRX.V, NVRO, SYK, BSX)

4 Of The Best Gold Stocks For 2024

ApeX Protocol Unveils Trade-to-Earn Round 2 with Enhanced Rewards Pool & Extra Layers of Incentives

RZ Publish Nooro Foot Massager Reviews: Why It Is Used In The United States?

RZ Publish Nooro Foot Massager Reviews: Why Is It Used In The United States?

NSAV Announces FINCEN Registration

JUST IN: PawFury and CoinMarketCap Join Forces For a Strategic Marketing Partnership

Dunstan Joins Horse Racing Syndicate Racing Club’s Stable